Table 2

Total number of publications related to gross domestic expenditures on Research and Development in billion USD of countries that have published more than 30 items on RSV

Rank	Country	No. of articles	R&D expenditure in % GDP	GDP in billion USD	R&D expenditure in billion USD	Articles/billion USD of R&D expenditure
1	Chile	33	0.38	258	0.98	33.72
2	Netherlands	231	1.97	879	17.34	13.32
3	South Africa	31	0.73	349	2.55	12.14
4	UK	583	1.70	2990	50.85	11.46
5	Argentina	31	0.61	529	3.24	9.56
6	Spain	160	1.23	1381	17.01	9.41
7	Canada	217	1.61	1783	28.73	7.55
8	Denmark	68	3.08	346	10.67	6.37
9	Sweden	99	3.16	571	18.05	5.49
10	Finland	46	3,17	272	8.63	5.33
11	USA	2139	2.73	17 348	472.78	4.52
12	Belgium	56	2.46	531	13.09	4.28
13	Italy	84	1.29	2138	27.52	3.05
14	Switzerland	62	2.97	701	20.80	2.98
15	France	189	2.26	2829	63.82	2.96
16	Australia	86	2.20	1454	31.93	2.69
17	Israel	33	4.11	305	12.53	2.63
18	Brazil	75	1.24	2417	29.87	2.51
19	Germany	196	2.87	3868	110.96	1.77
20	Russia	37	1.19	2030	24.09	1.54
21	Japan	192	3.58	4596	164.73	1.17
22	South Korea	36	4.29	1411	60.55	0.59
23	China*	93	2.05	10 351	211.79	0.44

GDP, gross domestic product; RSV, respiratory syncytial virus; R&D, Research and Development; USD, US dollars. *China without Taiwan.